Terminated PHASE4 INTERVENTIONAL 2-arm NCT01194297

Study of Live, Attenuated Influenza Vaccination in Preterm and Full-Term Infants

Immune Responses in Preterm and Full-Term Infants Following Live, Attenuated Influenza Vaccination

Sponsor: University of Rochester

Conditions Influenza

Interventions Inactivated influenza vaccine Live attenuated influenza vaccine

Updated 7 times since 2017 Last updated: Aug 4, 2014 Started: Aug 31, 2010 Primary completion: May 31, 2012 Completion: May 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Insufficient enrollment

Other terminated trials from University of Rochester

See all terminations from University of Rochester

Other Influenza trials with similar outcome

Browse all Influenza trials

This PHASE4 trial investigates Influenza and is currently terminated or withdrawn. University of Rochester leads this study, which shows 7 recorded versions since 2010 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE4
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE4
Jan 2023 — Jul 2024 [monthly]

Terminated PHASE4
Dec 2022 — Jan 2023 [monthly]

Terminated PHASE4
Jan 2021 — Dec 2022 [monthly]

Terminated PHASE4

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Terminated PHASE4
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE4

First recorded

Aug 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Rochester

Data source: University of Rochester

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.